Interactions between cAMP- and cGMP-dependent protein kinase inhibitors and phosphodiesterase IV inhibitors on arachidonate release from human monocytes
- 13 September 1996
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 59 (16), PL255-PL261
- https://doi.org/10.1016/0024-3205(96)00464-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Role of cyclic AMP in the modulation of IgE production by the beta 2-adrenoceptor agonist, fenoterolEuropean Respiratory Journal, 1996
- Involvement of cyclic AMP in the effects of phosphodiesterase IV inhibitors on arachidonate release from mononuclear cellsEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- (Rp)-8-pCPT-cGMPS, a novel cGMP-dependent protein kinase inhibitorEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Structure and Function of Cyclic Nucleotide-Dependent Protein KinasesAnnual Review of Physiology, 1994
- Inhibitors of Cyclic Nucleotide Phosphodiesterase Isoenzymes—their Potential Utility in the Therapy of AsthmaPulmonary Pharmacology, 1994
- The nitric oxide and cGMP signal transduction system: regulation and mechanism of actionBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1993
- Cross-activation: overriding cAMP/cGMP selectivities of protein kinases in tissuesBiochemistry and Cell Biology, 1992
- Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries.Journal of Biological Chemistry, 1992
- Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitorsTrends in Pharmacological Sciences, 1990
- Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide-dependent protein kinase and protein kinase CBiochemistry, 1984